← Browse by Condition
Medical Condition

metastatic prostate adenocarcinoma

Total Trials
4
Recruiting Now
4
Trial Phases
Phase 2
NCT05054296 Phase 2
Recruiting

Modifying Metabolic Syndrome and Cardiovascular Risk for Prostate Cancer Patients on ADT Using a Risk Factor Modification Program and Continuous Fitbit Monitoring

Enrollment
200 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center
View Trial →
NCT06850545
Recruiting

Kuopio Lutetium-177 Study in Patients with PSMA-Positive Metastatic Prostate Cancer

Enrollment
150 pts
Location
Finland
Sponsor
Kuopio University Hospital
View Trial →
NCT06039371 Phase 2
Recruiting

Supraphysiological Androgen to Enhance Treatment Activity in Metastatic Castration-Resistant Prostate Cancer, SPECTRA Study

Enrollment
69 pts
Location
United States
Sponsor
University of Washington
View Trial →
NCT05168618 Phase 2
Recruiting

Cabozantinib and Atezolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer, The AtezoCab Trial

Enrollment
33 pts
Location
United States
Sponsor
University of Utah
View Trial →